Acasti Pharma Inc. (ACST) Reaches $0.85 Yearly Low; Cypress Capital Group Raised By $355,650 Its Laboratory America Hldgs (LH) Stake

December 21, 2017 - By Richard Conner

The stock of Acasti Pharma Inc. (NASDAQ:ACST) hit a new 52-week low and has $0.82 target or 3.00% below today’s $0.85 share price. The 7 months bearish chart indicates high risk for the $12.38M company. The 1-year low was reported on Dec, 21 by Barchart.com. If the $0.82 price target is reached, the company will be worth $371,370 less. The stock decreased 27.97% or $0.33 during the last trading session, reaching $0.85. About 2.92 million shares traded or 457.27% up from the average. Acasti Pharma Inc. (NASDAQ:ACST) has declined 3.13% since December 21, 2016 and is downtrending. It has underperformed by 19.83% the S&P500.

Cypress Capital Group increased Laboratory Corp America Hldgs (LH) stake by 79.03% reported in 2017Q3 SEC filing. Cypress Capital Group acquired 2,371 shares as Laboratory Corp America Hldgs (LH)’s stock declined 0.17%. The Cypress Capital Group holds 5,371 shares with $811,000 value, up from 3,000 last quarter. Laboratory Corp America Hldgs now has $16.50B valuation. The stock decreased 0.61% or $0.99 during the last trading session, reaching $162.04. About 51,248 shares traded. Laboratory Corporation of America Holdings (NYSE:LH) has risen 10.51% since December 21, 2016 and is uptrending. It has underperformed by 6.19% the S&P500.

Investors sentiment decreased to 0.9 in 2017 Q3. Its down 0.16, from 1.06 in 2017Q2. It turned negative, as 41 investors sold LH shares while 239 reduced holdings. 70 funds opened positions while 181 raised stakes. 91.79 million shares or 1.82% less from 93.49 million shares in 2017Q2 were reported. Silvercrest Asset Management Gp Ltd Limited Liability Company invested in 466,193 shares or 0.7% of the stock. Bb&T Lc holds 7,030 shares or 0.01% of its portfolio. Thrivent Fincl For Lutherans invested 0.01% in Laboratory Corporation of America Holdings (NYSE:LH). Security Tru holds 0% of its portfolio in Laboratory Corporation of America Holdings (NYSE:LH) for 40 shares. Monetary Mgmt Gru stated it has 0.15% in Laboratory Corporation of America Holdings (NYSE:LH). Kcm Advsr Ltd reported 0.14% of its portfolio in Laboratory Corporation of America Holdings (NYSE:LH). Moreover, New York State Teachers Retirement System has 0.06% invested in Laboratory Corporation of America Holdings (NYSE:LH). Legal & General Gp Pcl reported 602,164 shares. Bkd Wealth Limited Liability Com holds 0.23% or 14,003 shares. Ancora Advsrs Lc reported 4,238 shares. Carderock Cap Incorporated accumulated 29,008 shares. Private Advisor Lc stated it has 0.01% of its portfolio in Laboratory Corporation of America Holdings (NYSE:LH). Teachers Retirement Systems Of The State Of Kentucky has 150,128 shares for 0.27% of their portfolio. Oakbrook Investments Ltd Liability Co invested 0.08% in Laboratory Corporation of America Holdings (NYSE:LH). Moreover, Leavell Invest has 0.11% invested in Laboratory Corporation of America Holdings (NYSE:LH) for 6,079 shares.

Among 18 analysts covering Laboratory Corp (NYSE:LH), 9 have Buy rating, 0 Sell and 9 Hold. Therefore 50% are positive. Laboratory Corp had 46 analyst reports since July 29, 2015 according to SRatingsIntel. The stock of Laboratory Corporation of America Holdings (NYSE:LH) has “Neutral” rating given on Friday, September 9 by Citigroup. On Thursday, September 15 the stock rating was maintained by Mizuho with “Neutral”. The stock of Laboratory Corporation of America Holdings (NYSE:LH) earned “Buy” rating by Craig Hallum on Thursday, October 26. The company was maintained on Tuesday, August 16 by KeyBanc Capital Markets. The firm earned “Overweight” rating on Tuesday, April 26 by Barclays Capital. Credit Suisse downgraded Laboratory Corporation of America Holdings (NYSE:LH) rating on Monday, December 11. Credit Suisse has “Hold” rating and $170.0 target. Goldman Sachs downgraded Laboratory Corporation of America Holdings (NYSE:LH) rating on Tuesday, December 8. Goldman Sachs has “Neutral” rating and $126 target. The rating was maintained by Piper Jaffray on Monday, October 16 with “Buy”. The stock of Laboratory Corporation of America Holdings (NYSE:LH) has “Hold” rating given on Wednesday, July 12 by Credit Suisse. The rating was upgraded by Wells Fargo to “Buy” on Thursday, October 12.

Cypress Capital Group decreased Ishares (IJH) stake by 1,894 shares to 16,084 valued at $2.88M in 2017Q3. It also reduced Kimberly (NYSE:KMB) stake by 2,612 shares and now owns 15,681 shares. Peoples United Financial Inc (NASDAQ:PBCT) was reduced too.

Since August 1, 2017, it had 0 insider purchases, and 7 insider sales for $14.75 million activity. EBERTS F SAMUEL III had sold 31,500 shares worth $4.89 million. 971 shares were sold by Gilliland Dwight Gary, worth $149,068. 5,000 shares were sold by Uthgenannt Lisa J, worth $800,000 on Tuesday, August 1. Another trade for 2,871 shares valued at $459,739 was sold by Dodson Edward T. KING DAVID P sold $7.01M worth of stock or 44,687 shares. Williams R Sanders had sold 3,100 shares worth $486,338 on Friday, August 11. EISENBERG GLENN A sold $951,672 worth of stock.

Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of prescription drugs for the treatment of cardiovascular diseases. The company has market cap of $12.38 million. The company's lead product candidate is CaPre, an omega-3 phospholipid for the treatment of hypertriglyceridemia. It currently has negative earnings.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: